Literature DB >> 2148552

Reactive astrogliosis after basic fibroblast growth factor (bFGF) injection in injured neonatal rat brain.

F Eclancher1, F Perraud, J Faltin, G Labourdette, M Sensenbrenner.   

Abstract

Reactive gliosis was revealed by immunocytochemistry using antibodies against the glial fibrillary acidic protein (GFAP) after a stab or an electrolytic lesion administered to the cerebral cortex, corpus callosum, striatum, or hippocampus of a 6-day-old rat. The intensity of the gliosis was about the same in the various structures injured and did not change with the delay of 3, 7, or 20 days between the injury and the sacrifice of the animals. When basic fibroblast growth factor (bFGF) was injected in the lesion locus just after the lesion was performed, it resulted (as soon as 3 days after injury) in a strong astrogliosis that was enhanced after a delay of 7 days, the astrocytes in the lesion area exhibiting enlarged cell processes and intense GFAP-positive immunoreactivity. After a delay of 20 days, the astrocytes were not dispersed any more but packed in three or four layers along the borders of the lesion, thus reducing its extension. This suggests a possible role for bFGF in promoting scar formation following brain injury.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148552     DOI: 10.1002/glia.440030609

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  13 in total

1.  Differential responsiveness of late passage C-6 glial cells and advanced passages of astrocytes derived from aged mouse cerebral hemispheres to cytokines and growth factors: glutamine synthetase activity.

Authors:  T Kazazoglou; E Fleischer-Lambropoulos; T Geladopoulos; S Kentroti; C Stefanis; A Vernadakis
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

2.  Astrocyte activation is suppressed in both normal and injured brain by FGF signaling.

Authors:  Wenfei Kang; Francesca Balordi; Nan Su; Lin Chen; Gordon Fishell; Jean M Hébert
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

3.  Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain.

Authors:  Francesca Madiai; Virginia M Goettl; Syed-Rehan Hussain; Alec R Clairmont; Robert L Stephens; Kevin V Hackshaw
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Protective effect of basic fibroblast growth factor on laser induced retinopathy.

Authors:  Unal Kartal; Emel Koptagel; H Eray Bulut; Haydar Erdogan
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

Review 5.  Targeting astrocyte signaling for chronic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

6.  Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway.

Authors:  Ru-Rong Ji; Yasuhiko Kawasaki; Zhi-Ye Zhuang; Yeong-Ray Wen; Isabelle Decosterd
Journal:  Neuron Glia Biol       Date:  2006-11

Review 7.  Activation of JNK pathway in persistent pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurosci Lett       Date:  2008-03-13       Impact factor: 3.046

8.  Increase of basic fibroblast growth factor immunoreactivity and its mRNA level in rat brain following transient forebrain ischemia.

Authors:  K Takami; M Iwane; Y Kiyota; M Miyamoto; R Tsukuda; S Shiosaka
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

9.  Upregulation of fibroblast growth factor-receptor messenger RNA expression in rat brain following transient forebrain ischemia.

Authors:  K Takami; Y Kiyota; M Iwane; M Miyamoto; R Tsukuda; K Igarashi; A Shino; A Wanaka; S Shiosaka; M Tohyama
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Clonal astrocytic response to cortical injury.

Authors:  Eduardo Martín-López; Jorge García-Marques; Raúl Núñez-Llaves; Laura López-Mascaraque
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.